KENILWORTH, N.J., July 17 Schering-PloughCorporation (NYSE: SGP) today announced that Schering-Plough K.K., thecompany's country operation in Japan, has received marketing approval forNASONEX(R) ...

Nasacort and Nasonex are both allergy nasal sprays that contain drugs called corticosteroids. With allergies, the body’s immune system responds to an allergen, or trigger. This causes symptoms such as ...

A once-daily dose of Schering-Plough’s allergy drug, Nasonex (mometasone), is safe and effective for the treatment of nasal polyps and nasal congestion related to the condition, according to new ...

Nasonex is currently approved in more than 100 countries and is anticipated to be available in Japan this fall.Schering-Plough Corp. (NYSE: SGP) of Kenilworth said today that its Japanese unit has ...

The FDA’s Division of Drug Marketing, Advertising and Communications has issued untitled letters of violation to Schering-Plough for its Nasonex nasal spray, and to GlaxoSmithKline for its Flonase ...

DTC TV prescription drug ads featuring an animated bee and a talking beaver were most recalled by consumers during 2007, according to ad performance tracking firm IAG Research. A 30-second spot ...

June 15 (Reuters) - Merck & Co, Inc lost a patent infringement lawsuit against Apotex Inc on Friday over Apotex's plans to market a generic version of the nasal allergy spray Nasonex. Sign up here.

Merck, Sharp & Dohme Corp. has filed a second suit to halt plans by Apotex Inc. for a generic version of Merck's popular nasal spray, Nasonex, after the company's previous patent infringement suit in ...

IAG Research released its top-10 list of most-recalled new pharma ads of 2007. Many familiar faces top the list, including the Nasonex bee, Abe Lincoln, and Dr. Jarvik, but how many of those faces ...

With spring allergies in the air, two prescription-products-gone-over-the-counter recently – Astepro and Nasonex -- have sprung creative campaigns. Surrounded by flowers, and clothed and posed as if ...

Although the court ruled that the patent is valid, it also said that Apotex’s product would not infringe on the patent. Merck had filed a patent infringement suit against Apotex in December 2009. The ...

Last week, on Friday, June 15, 2012, Merck (NYSE: MRK) announced the U.S. District Court for the District of New Jersey (Judge Peter G. Sheridan) ruled against the company on the issue of patent ...